BioLineRx Ltd (BLRX) — Cash Flow Reinvestment Rate

Latest as of December 2023: 4.09x

BioLineRx Ltd (BLRX) has a Cash Flow Reinvestment Rate of 4.09x as of December 2023, reinvesting $20.41 Million (capex $18.00K plus investments $-20.39 Million) from operating cash flow of $4.99 Million. Explore BioLineRx Ltd (BLRX) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

4.09x

(Capex + Investments) / Operating CF

Total Reinvested

$20.41 Million

Capex + Investments

Operating Cash Flow

$4.99 Million

USD

Capital Expenditures

$18.00K

USD

BioLineRx Ltd Cash Flow Reinvestment Rate (2010–2010)

Historical reinvestment intensity for BioLineRx Ltd across 1 annual periods. Also explore BLRX asset base for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for BioLineRx Ltd (2010–2010)

Year-by-year capital reinvestment analysis for BioLineRx Ltd. For live market cap and broader valuation context, see market value of BioLineRx Ltd.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2010	0.06x	$660.94K	$11.46 Million	$660.94K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow